. 2019 May 26;27(1):283–293. doi: 10.1007/s40199-019-00274-3

Table 1.

Assessing of the epidermal thickness (with and without the corneum layer) and Ki67 expression by morphological evaluation

Treatments	RHE total thickness (micron)	RHE thickness w/o corneum layer (micron)	Ki67/mm
SMM	92.67 ± 7.23	19.40 ± 1.01	7 ± 0.47
PBS 1X	122.00 ± 8.72^*	32.73 ± 1.60^#	15 ± 0.80^#
LPS 100 μg/mL	168.00 ± 3.60^#	42.53 ± 1.76^#	12 ± 0.75^#
PBS 1X + 10 μM Dexamethasone	119.00 ± 6.00^*	37.97 ± 2.91^#	7 ± 0.50^δ
LPS 100 μg/mL + 10 μM Dexamethasone	88.00 ± 1.00^φ	34.30 ± 1.37^#§	7 ± 0.53^φ
PBS 1X + Fenolia® Eudermal Cream 15	104.67 ± 6.51^ψ	27.50 ± 1.80^*ψ	6 ± 0.20^δ
LPS 100 μg/mL + Fenolia® Eudermal Cream 15	142.33 ± 8.74^*§	41.03 ± 2.99^#	34 ± 0,80^#φ

Results were expressed as mean ± standard deviation of three independent experiments (n = 3)

*P ≤ 0.05 vs SMM; ^#P ≤ 0.001 vs SMM; ^ψP ≤ 0.05 vs PBS 1 X; ^δP ≤ 0.001 vs PBS 1 X; ^§P ≤ 0.05 vs LPS 100 μg/mL; ^φP ≤ 0.001 vs LPS 100 μg/mL